Mirae Asset Global Investments’s TNF Pharmaceuticals, Inc. Common Stock TNFA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-8,759
| Closed | -$1.28M | – | 2587 |
|
|
2024
Q1 | $1.28M | Buy |
8,759
+7,723
| +745% | +$1.13M | ﹤0.01% | 1407 |
|
|
2023
Q4 | $804K | Buy |
1,036
+722
| +230% | +$560K | ﹤0.01% | 1730 |
|
|
2023
Q3 | $557K | Sell |
314
-81
| -21% | -$144K | ﹤0.01% | 1831 |
|
|
2023
Q2 | $1.78M | Buy |
395
+4
| +1% | +$18K | ﹤0.01% | 1273 |
|
|
2023
Q1 | $2.02M | Buy |
391
+139
| +55% | +$718K | ﹤0.01% | 1201 |
|
|
2022
Q4 | $870K | Buy |
252
+39
| +18% | +$135K | ﹤0.01% | 1573 |
|
|
2022
Q3 | $1.67M | Sell |
213
-145
| -41% | -$1.13M | ﹤0.01% | 1224 |
|
|
2022
Q2 | $2.33M | Buy |
358
+43
| +14% | +$280K | 0.01% | 1099 |
|
|
2022
Q1 | $4.4M | Buy |
315
+60
| +24% | +$838K | 0.01% | 920 |
|
|
2021
Q4 | $4.63M | Sell |
255
-122
| -32% | -$2.22M | 0.01% | 904 |
|
|
2021
Q3 | $8.15M | Buy |
+377
| New | +$8.15M | 0.02% | 711 |
|